Meningitis B vaccine 'not cost effective'
The only vaccine to protect against a deadly form of meningitis should not be introduced in the UK, the body that advises governments on immunisation says.
About 1,870 people contract meningitis B each year and one in 10 dies.
The Joint Committee on Vaccination and Immunisation said the vaccine, Bexsero, was not cost-effective and should not yet be adopted by the NHS.
Meningitis charities have been campaigning for it to be introduced.
Fergus Walsh reports.
24 Jul 2013